Revenue from Contract with Customer, Excluding Assessed Tax in USD of Iterum Therapeutics plc from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Iterum Therapeutics plc quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and change rate from 2016 to Q3 2025.
  • Iterum Therapeutics plc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Sep 2025 was $390K.
  • Iterum Therapeutics plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $0.000.
  • Iterum Therapeutics plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $0.000, a 100% decline from 2019.
  • Iterum Therapeutics plc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2019 was $37K, a 95.7% decline from 2018.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)

Iterum Therapeutics plc Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $390K 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q1 2019 $715K $37K -$154K -80.6% 01 Jan 2019 31 Mar 2019 10-K 12 Mar 2021
Q4 2018 $869K $239K 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 $254K +$95K +59.7% 01 Jul 2018 30 Sep 2018 10-K 12 Mar 2020
Q2 2018 $185K 01 Apr 2018 30 Jun 2018 10-K 12 Mar 2020
Q1 2018 $191K 01 Jan 2018 31 Mar 2018 10-K 12 Mar 2020
Q3 2017 $159K 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018

Iterum Therapeutics plc Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $0 $0 01 Jan 2021 31 Dec 2021 10-K 28 Mar 2022
2020 $0 -$37K -100% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2022
2019 $37K -$832K -95.7% 01 Jan 2019 31 Dec 2019 10-K 28 Mar 2022
2018 $869K +$361K +71.1% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2021
2017 $508K +$508K 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020
2016 $0 01 Jan 2016 31 Dec 2016 10-K 25 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.